Michael LopezThe claim that cellular recycling slows with age is repeated so often that it can sound like a universal rule. Direct measurements in human cells suggest a more complicated picture. Depending on the cell type and the person’s sex, autophagy activity may decrease, remain stable, or increase.
A study led by Tatiana Moreno and Caroline Kumsta examined those differences using cells from human donors and measurements of autophagy flux, the rate at which material moves through the recycling process. The results challenge a simple assumption without establishing an equally simple replacement. Higher activity is not automatically evidence of a healthier cell. [1]
What is autophagy flux, and why measure it?
Autophagy allows cells to package and degrade material through lysosomal pathways. A measurement of flux asks how actively that process is running over a period of time. It differs from measuring how much of an autophagy-related protein is present at one moment.
That distinction can be illustrated with a sink. A large amount of water could reflect a running tap, a blocked drain, or both. The water level alone does not reveal the flow. In a cell, a static accumulation of pathway components can likewise have more than one explanation.
The field’s assay guidelines emphasize the need for complementary methods and caution against relying on a single measurement across experimental settings. [2] For aging research, that makes direct functional measurements especially valuable. A pathway’s name appearing in a gene-expression analysis does not establish the speed or effectiveness of the process itself.
How autophagy changed across human cell types
The researchers examined dermal fibroblasts, induced neurons generated from donor fibroblasts, and freshly isolated peripheral blood mononuclear cells. Using related samples helped them compare cellular systems while retaining information about the people who supplied them. [1]
The age-associated pattern was not uniform. Flux declined in male fibroblasts, remained stable in female fibroblasts, and increased in female induced neurons. Blood-cell measurements became more heterogeneous with age and tended to be higher in older participants. Changes in autophagy-related gene expression did not map neatly onto changes in measured flux. [1]
These are results from particular sampled cells and experimental conditions. Induced neurons are not a direct measurement of recycling throughout a living person’s brain, and blood cells cannot stand in for every organ.
Even with those limits, the comparison is informative. A claim about “autophagy in aging” needs to specify the process measured, the cell population, and the population of people being studied. Otherwise, results that appear contradictory may simply concern different biological settings.
The direction of change depended on the sample being measured:
| Cell population | Reported age-associated flux pattern |
| Male dermal fibroblasts | Decreased |
| Female dermal fibroblasts | Remained stable |
| Female induced neurons | Increased |
| Peripheral blood mononuclear cells | More variable, with a tendency toward higher values in older donors |
These comparisons summarize the study’s measured populations; they should not be extended to unmeasured tissues. [1]
Why higher autophagy was linked to poorer function in older adults
Among participants older than 70, higher flux was associated with reduced physical function. The authors suggest that elevated activity could sometimes reflect a compensatory response to age-related stress rather than superior maintenance. [1]
That is a plausible interpretation, not a demonstrated causal explanation. The association does not show that excessive autophagy caused the functional limitation, nor does it establish that reducing activity would improve health.
The distinction matters for intervention design. A system working harder may be responding appropriately to a greater burden. Turning it down could be helpful if the response itself is harmful, but harmful if it is protecting against an underlying problem. Conversely, increasing it may be useful in one context and unnecessary in another.
Determining which explanation applies requires experiments that change the pathway and follow the consequences. An age association, even one measured carefully, cannot make that decision alone.
What happened after the exercise intervention?
The study also included a small pilot involving five adults aged 77–88. After a 12-week mild exercise program, blood-cell autophagy flux decreased alongside improvements in physical performance. The program focused on balance, strength, and posture. [1]
This is a useful feasibility result: the measurement changed over an intervention period in older adults. It is not enough to establish that exercise improved function by lowering autophagy. With so few participants, the result needs replication and a suitable comparison group.
Future trials could ask whether the change predicts an individual’s functional response, whether it appears in other cell types, and how long it persists. Measurements taken at multiple time points would help distinguish an early adaptation from a stable effect.
The small pilot should therefore be reported as a starting point for a larger study, rather than a general exercise mechanism or a clinical test of biological age.
What this means for autophagy supplements and longevity claims
This research does not test a supplement. It also does not establish that raising or lowering autophagy across the body is a useful goal in itself.
When evaluating a product claim, readers should ask whether the evidence concerns actual pathway activity in people, a marker in cultured cells, or a theoretical mechanism. They should also ask whether the measured change accompanied an outcome that matters to health.
An intervention could alter a blood-cell assay without improving muscle, cognition, or disease risk. It could also improve function through a different mechanism while autophagy changes alongside it. Both possibilities require more careful language than “activates cellular cleanup.”
The study’s value is that it encourages better measurement. It offers no basis for treating an isolated assay result as a personal target or for assuming that more activity always means more benefit.
The next question is which response helps which person
A larger, controlled exercise study would be a sensible next step. Researchers could prespecify physical outcomes, examine sex-related differences, and determine whether baseline flux identifies people who respond differently. Repeated sampling could establish how stable the assay is within an individual.
The work also supports more careful use of molecular data. If gene expression and functional flux can diverge, researchers should avoid treating a transcriptional signature as proof that recycling has improved.
The broader lesson is specific rather than sweeping: autophagy changes during human aging, and those changes depend on the cells and people being measured. A useful longevity intervention will have to improve function in that biological context. A higher pathway score alone will not answer the question.
Sources
- Moreno TM, Heimler SR, Moran RJ, et al. Autophagy Flux Is Remodeled Sex- and Cell Type-Specifically During Human Aging, and Is Linked to Reduced Physical Function in Older Adults. Aging Cell. 2026;25:e70734. https://doi.org/10.1111/acel.70734. Open full text.
- Klionsky DJ, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021;17:1–382. https://doi.org/10.1080/15548627.2020.1797280.
